Sandra Levy
ARTICLES BY THIS AUTHOR
- 9/14/2023
CVS Pharmacy, FARE partner for Teal Pumpkin Project
Beginning with the 2023 Halloween season, the partnership extends food allergy inclusivity to holidays throughout the year. - 9/13/2023
Walgreens receives AAHP's Integrative Medicine Retailer award
The award recognizes a retailer or retailer executive that promotes and sells products that encompass a broad range of therapeutic approaches. - 9/13/2023
Lupin partners with Mark Cuban Cost Plus Drug Company, COPD Foundation to expand medication access
Lupin’s Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, is the only generic product available that is therapeutically equivalent to Boehringer Ingelheim’s Spiriva HandiHaler. - 9/13/2023
Sanofi, Ice-T roll out horror-movie themed flu campaign
The trailer taps into suspenseful movie tropes to educate older adults, particularly those with chronic health conditions, about the risks associated with the flu. - 9/13/2023
Retailers offer OTC Narcan nasal spray
Retailers, including Rite Aid and Walgreens, are offering Narcan Nasal Spray without a prescription. - 9/12/2023
Albertsons launches 30-minute grocery pickup and delivery with New Flash service
More than 2,000 store locations now offer speed and convenience on thousands of items at in-store prices. - 9/12/2023
Giant Food expands Flexible Rewards Loyalty Program with pharmacy offerings
Giant customers can now earn points through qualifying pharmacy transactions. - 9/12/2023
Kellogg board approves separation into 2 companies
Kellogg Company will be renamed Kellanova, and will continue to trade on the New York Stock Exchange under the ticker symbol "K," while WK Kellogg Co is expected to begin trading under the ticker symbol "KLG." - 9/12/2023
Amneal obtains FDA OK for calcium gluconate injection
Calcium gluconate in sodium chloride injection is a small volume parenteral bag indicated for the treatment of acute symptomatic hypocalcemia in pediatric and adult patients. - 9/11/2023
Sandoz inks deal with Samsung Bioepis to commercialize Stelara biosimilar
Ustekinumab is a fully human monoclonal antibody to interleukin (IL)-12/23, approved for treatment of plaque psoriasis, psoriatic arthritis, Crohn´s disease and ulcerative colitis.
